Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
EMA Calls For Zinbryta's ‘Immediate’ Suspension After More Reports of Brain Disorders
Mar 07 2018
•
By
Ian Schofield
The EMA has recommended suspending and recalling Zinbryta after 12 reports of serious brain disorders
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from Drug Safety
More from Pink Sheet